STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals

The Trump administration has revised the terms of a pilot effort that will allow some drugmakers to offer rebates to certain hospitals and clinics for purchased medicines, a controversial move that may transform a key tenet of a federal drug discount program. The anticipated pilot for the 340B Drug Pricing Program, which is slated to go into effect on Jan. 1, 2027, will allow pharmaceutical companies to provide “timely” rebates, rather than offering upfront discounts. The program targets specifi...